Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/53935
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSiok Shen Ngen_US
dc.contributor.authorNai Ming Laien_US
dc.contributor.authorSurakit Nathisuwanen_US
dc.contributor.authorNowrozy Kamar Jahanen_US
dc.contributor.authorPiyameth Dilokthornsakulen_US
dc.contributor.authorKhachen Kongpakwattanaen_US
dc.contributor.authorWilliam Hollingworthen_US
dc.contributor.authorNathorn Chaiyakunapruken_US
dc.contributor.otherTaylor's University Malaysiaen_US
dc.contributor.otherUniversity of Utahen_US
dc.contributor.otherNaresuan Universityen_US
dc.contributor.otherMonash University Malaysiaen_US
dc.contributor.otherUniversity of Bristol, Faculty of Medicine and Dentistryen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherHospital Melakaen_US
dc.date.accessioned2020-03-26T05:18:47Z-
dc.date.available2020-03-26T05:18:47Z-
dc.date.issued2020-12-01en_US
dc.identifier.citationScientific Reports. Vol.10, No.1 (2020)en_US
dc.identifier.issn20452322en_US
dc.identifier.other2-s2.0-85078301091en_US
dc.identifier.urihttp://repository.li.mahidol.ac.th/dspace/handle/123456789/53935-
dc.description.abstract© 2020, The Author(s). Warfarin care bundles (e.g. genotype-guided warfarin dosing, patient’s self-testing [PST] or patient’s self-management [PSM] and left atrial appendage closure) are based on the concept of combining several interventions to improve anticoagulation care. NOACs are also introduced for stroke prevention in atrial fibrillation (SPAF). However, these interventions have not been compared in head-to-head trials yet. We did a network meta-analysis based on a systematic review of randomized controlled trials comparing anticoagulant interventions for SPAF. Studies comparing these interventions in adults, whether administered alone or as care bundles were included in the analyses. The primary efficacy outcome was stroke and the primary safety outcome was major bleeding. Thirty-seven studies, involving 100,142 patients were assessed. Compared to usual care, PSM significantly reduced the risk of stroke (risk ratio [RR] 0.24, 95% CI 0.08–0.68). For major bleeding, edoxaban 60 mg (0.80, 0.71–0.90), edoxaban 30 mg (0.48, 0.42–0.56), and dabigatran 110 mg (0.81, 0.71–0.94) significantly reduced the risk of major bleeding compared with usual warfarin care. Cluster rank plot incorporating stroke and major bleeding outcomes indicates that some warfarin care bundles perform as well as NOACs. Both interventions are therefore viable options to be considered for SPAF. Additional studies including head-to-head trials and cost-effectiveness evaluation are still warranted.en_US
dc.rightsMahidol Universityen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85078301091&origin=inwarden_US
dc.subjectMultidisciplinaryen_US
dc.titleComparative efficacy and safety of warfarin care bundles and novel oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysisen_US
dc.typeArticleen_US
dc.rights.holderSCOPUSen_US
dc.identifier.doi10.1038/s41598-019-57370-2en_US
dc.identifier.urlhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85078301091&origin=inwarden_US
Appears in Collections:Scopus 2020

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.